Exelixis’ Partner Ipsen Announces Health Canada’s Approval of CABOMETYX (cabozantinib) Tablets for the Treatment of Adults with Previously Treated Advanced Renal Cell Carcinoma
pharmaceutical investing “We’re Financially Prudent,” Says CFO and President of Knight Therapeutics Samira Sakhia
cannabis investing Maricann Announces Phase One of Its Canadian Expansion is Ready to Grow Ahead of Schedule
cannabis investing CannTrust™ Announces Receiving Health Canada Approval to Export Medical Marijuana Internationally and the Shipping of Medical Marijuana to Australia Français
cannabis investing Maple Leaf Green World Inc. Announces Progress Report From Cannabis Compliance Inc.
Standard Uranium Executes Definitive Agreement to Option Rocas Uranium Project and Initiates Inaugural Exploration Program
Blue Sky Uranium Launches Exploration Program after Completing Ivana Deposit Infill Drilling Program and Advances towards Prefeasibility Study at Amarillo Grande Project, Argentina
